Page 3 - Best Lung cancer stage 4 doctors: TOP 81 doctors

Specializes in virotherapy – a cutting-edge approach to treating lung cancer with over 49 years of experience of experience.

• Graduate of Riga Medical Institute
• Internship in Internal Medicine
• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital

Specializes in minimally invasive robotic and thoracoscopic surgeries for lung cancer – Dr. Dobritoiu uses small incisions for faster recovery at Ponderas Academic Hospital.

• Expert in robotic thoracic surgery using da Vinci Xi system
• Performs video-assisted thoracoscopic surgery (VATS), including uniportal VATS
• Skilled in complex pulmonary and mediastinal resections
• Offers minimally invasive procedures without postoperative pleural drainage

Professor Gul Alco specializes in radiation oncology for lung cancer at Medipol Acibadem District Hospital.

• Over 31 years of experience of experience in radiation oncology
• Professor at Istanbul Medipol University
• Trained at Istanbul University and Kadir Has University
• Worked at Şişli Florence Nightingale Hospital

Dr. Ozden specializes in treating advanced lung cancer at VM Medical Park Pendik Hospital, with extensive training and practice in medical oncology.

• Graduated from Istanbul University Cerrahpaşa Faculty of Medicine
• Completed medical oncology subspecialty at Kocaeli University
• Over a decade of experience in internal medicine and oncology
• Worked at Şırnak State Hospital focusing on medical oncology

Dr. Zalmanova specializes in radiotherapy for lung cancer at Assuta Medical Center.

• Radiotherapist with a focus on lung cancer treatment
• Works at Assuta Medical Center, a leading facility in oncology care
• Dedicated to personalized treatment plans for each patient

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Meirovitz brings decades of oncology expertise to Hadassah Medical Center, one of Israel's leading hospitals.

• Graduated from Technion University's Faculty of Medicine in 1990
• Specializes in advanced-stage lung cancer treatments
• Practices at Hadassah – a top-tier medical institution

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Professor Tamar Jablonski-Perec heads the Institute of Oncology at Hadassah Medical Center, with training from Sloan-Kettering Cancer Center.

• Over leading oncology programs
• Specializes in advanced breast and lung cancer treatment
• Member of international cancer research communities
• Professor at Hebrew University's oncology department
• Awarded prestigious Hadassah Medical School scholarship

Specializes in thoracic surgical oncology, including advanced lung cancer surgeries at Medical Park Göztepe Hospital Complex. Offers VATS (Video Assisted Thoracoscopic Surgery) for precise, minimally invasive procedures.

• Extensive experience in lung cancer surgery and pleural disease treatments
• Trained at University of Paris-Sud and Marie-Lannelongu Hospital, France
• Member of the European Society of Thoracic Surgeons
• Published numerous papers on thoracic surgery topics

Dr. Semenisity specializes in medical oncology and radiotherapy at Rambam Medical Center.

• Expert in advanced lung cancer treatments
• Focuses on personalized therapy plans
• Works with a multidisciplinary team

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Specializes in minimally invasive thoracic surgery for lung cancer – Dr. Adnansayar performs thoracoscopic and robotic procedures at Liv Hospital Ulus.

• Focused on lung cancers and trachea surgery
• Skilled in lung transplantation and pleural disease surgery
• Also experienced in pediatric thoracic surgeries
• Graduated from Istanbul University Faculty of Medicine

Author of 30+ scientific papers on malignancy treatment – Dr. Derin is a leading oncologist at Liv Hospital Ulus.

• Specializes in gastrointestinal and lung cancers
• Member of European Society for Medical Oncology (ESMO)
• Associate Professor with extensive academic experience
• Graduated from Istanbul University Medical Faculty